DUKE CAPITAL LIMITED – Result Of Annual General Meeting
RNS Number : 0600S Duke Capital Limited 25 August 2026 25 August 2026 Duke Capital Limited (“Duke
RNS Number : 0600S Duke Capital Limited 25 August 2026 25 August 2026 Duke Capital Limited (“Duke
RNS Number : 6791K Duke Capital Limited 02 July 2026 2 July 2026 Duke Capital Limited (“Duke
Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to provide the following trading and operational update for its fourth financial quarter ended 31 March 2021 (“Q4 FY21”), and to provide guidance on trading for the first quarter of the Company’s financial year ended 30 June 2021 (“Q1 FY22”).
Almost all companies have been affected by the coronavirus pandemic and AIM-listed Surgical Innovations is no exception. The suspension of all non-urgent surgical procedures by the NHS in mid-March
Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to provide the following trading update for its second financial quarter ending 30 September 2020 (“Q2 FY21”).
Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad,
Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has entered into a new £30 million revolving facility agreement with its existing provider, Honeycomb Investment Trust PLC (the “New Credit Facility”), on improved terms.
Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce its final results for the 12 months ended 31 March 2019 (“FY19”).